RAMASITA PISIPATI: Open Payments
NPI 1992812556 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,748 in 118 payments from 26 companies in 2025. Trend: 2023 $2,273 · 2024 $2,497 · 2025 $2,748
Food & beverage: $2,748
| Company | Payments | Amount |
|---|---|---|
| SHIELD THERAPEUTICS INC | 3 | $338 |
| ABBVIE INC. | 11 | $245 |
| Abbott Laboratories | 11 | $225 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 18 | $222 |
| Novo Nordisk Inc | 11 | $203 |
| Amgen Inc. | 9 | $170 |
| Otsuka America Pharmaceutical, Inc. | 2 | $148 |
| AstraZeneca Pharmaceuticals LP | 7 | $142 |
| GlaxoSmithKline, LLC. | 6 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $108 |
Products named: ACCRUFER, XIFAXAN, Ozempic, FREESTYLE LIBRE, REXULTI, TRELEGY ELLIPTA, CAPLYTA, VOQUEZNA.
Industry payments across NY — which companies pay providers there.
